Cover Image

Increase of antitumor activity of cisplatin using agonist of gonadotropin-realising hormone and inhibitor of aromatase on the model of ascites ovarian tumor

Saved in:

Bibliographic Details
Date:	2014
Main Authors:	I. G. Tkalia, L. I. Vorobyova, A. N. Grabovoy, V. S. Svintsitsky, T. O. Tarasova, N. Y. Lukyanova, I. N. Todor, V. F. Chekhun
Format:	Article
Language:	English
Published:	2014
Series:	Experimental Oncology
Online Access:	http://jnas.nbuv.gov.ua/article/UJRN-0000294117
Tags:	Add Tag No Tags, Be the first to tag this record!
Journal Title:	Library portal of National Academy of Sciences of Ukraine \| LibNAS

Institution

Library portal of National Academy of Sciences of Ukraine | LibNAS

Similar Items

The antitumor efficacy of cisplatin in combination with triptorelin and exemestane therapy for an ovarian cancer ascites model in Wistar rats
by: I. G. Tkalia, et al.
Published: (2015)

Clinical significance of hormonal receptor status of malignant ovarian tumors
by: I. G. Tkalia, et al.
Published: (2014)

Clinical significance of hormonal receptor status of malignant ovarian tumors
by: Tkalia, I.G., et al.
Published: (2014)

Antitumor and antimetastatic activities of vaccine prepared from cisplatin-resistant lewis lung carcinoma
by: Potebnya, G.P., et al.
Published: (2009)

Peculiarities of antioxidant system and iron metabolism in organism during development of tumor resistance to cisplatin
by: Chekhun, V.F., et al.
Published: (2014)

Peculiarities of antioxidant system and iron metabolism in organism during development of tumor resistance to cisplatin
by: V. F. Chekhun, et al.
Published: (2014)

Gastric signet-ring cell carcinoma with hypersecretion of β-Human chorionic gonadotropin and review of the literature
by: Ben Kridis, W., et al.
Published: (2018)

The lipid content of cisplatin- and doxorubicin-resistant MCF-7 human breast cancer cells
by: Todor, I.N., et al.
Published: (2012)

Recurrence of borderline ovarian tumors
by: V. S. Svintsitskiy, et al.
Published: (2013)

Molecular profile and cell cycle in mcf-7 cells resistant to cisplatin and doxorubicin
by: Lukyanova, N.Yu., et al.
Published: (2009)

Recurrence of borderline ovarian tumors
by: Svintsitskiy, V.S., et al.
Published: (2013)

Synergic carcinostatic effects of ascorbic acid and hyperthermia on Ehrlich ascites tumor cell
by: Saitoh, Y., et al.
Published: (2015)

Synergic carcinostatic effects of ascorbic acid and hyperthermia on Ehrlich ascites tumor cell
by: Y. Saitoh, et al.
Published: (2015)

Behavioral and Electrophysiological Study of Thermal and Mechanical Pain Modulation by TRP Channel Agonists
by: M. G. Tsagareli, et al.
Published: (2013)

Behavioral and Electrophysiological Study of Thermal and Mechanical Pain Modulation by TRP Channel Agonists
by: Tsagareli, M.G., et al.
Published: (2013)

Antineoplastic therapy by radioactive cisplatin in experiment
by: Dikiy, N.P., et al.
Published: (2007)

Ferrofluids based cisplatin for application in cancer therapy
by: N. V. Abramov
Published: (2013)

Cyclin-dependent kinases 4/6 inhibitors in combination with aromatase inhibitors in treatment of metastatic breast cancer (clinical observation)
by: M. V. Sadchykova, et al.
Published: (2020)

Characteristics of homocysteine-induced multidrug resistance of human MCF-7 breast cancer cells and human A2780 ovarian cancer cells
by: Lukyanova, N.Yu.
Published: (2010)

Rating geno-and cytotoxic action of colloidal gold nanoparticles on the erythroid cells of the bone marrow and tumors in animals with ascitic Ehrlich carcinoma
by: Yu. V. Lozovska, et al.
Published: (2015)

Antitumor and genotoxic effects of lactoferrin in Walker-256 tumor-bearing rats
by: Chekhun, V.F., et al.
Published: (2018)

Ovarian tissue vitrification
by: V. A. Feskov, et al.
Published: (2014)

In vitro modification of cisplatin cytotoxicity with magnetic fluid
by: Chekhun, V.F., et al.
Published: (2013)

Promotive effects of hyperthermia on the сytostatic activity to ehrlich ascites tumor cells by diverse delta-alkyllactones
by: Tanaka, H., et al.
Published: (2008)

Rhenium–platinum antitumor systems
by: A. V. Shtemenko, et al.
Published: (2017)

Hormonal-sensitive breast cancer: molecular-biological and clinical aspects of preoperative antitumor hormone therapy
by: O. V. Ponomareva
Published: (2018)

Comparative investigation of the effect of Ukrain on growth of ascite and solid forms of ehrlich’s carcinoma
by: Susak, Ya.M., et al.
Published: (2010)

Magnetically sensitive nanocomposites for targeted antitumor therapy with application of gemcitabine
by: N. M. Korniichuk, et al.
Published: (2020)

Aggregation processes in hybrid nanosystem polymer/nanosilver/cisplatin
by: N. Kutsevol, et al.
Published: (2018)

Aggregation processes in hybrid nanosystem polymer/nanosilver/cisplatin
by: N. Kutsevol, et al.
Published: (2018)

Enterosorption as a method to decrease the systemic toxicity of cisplatin
by: Sakhno, L.A., et al.
Published: (2013)

General clinical, biochemical parameters and peripheral blood hormone level in women at ovarian hyperstimulation syndrome
by: N. V. Avramenko, et al.
Published: (2018)

Promotive effects of hyperthermia on the inhibition of DNA synthesis in Ehrlich ascites tumor cells by eicosapentaenoic and docosahexaenoic acids
by: Tanaka, H., et al.
Published: (2006)

Antitumor and antimetastatic efficiency of antitumor vaccine and amixin combined action in mice with Lewis lung carcinoma
by: G. V. Didenko, et al.
Published: (2016)

Hypoxia enhances antitumor activity of dichloroacetate
by: D. L. Kolesnik, et al.
Published: (2014)

Hypoxia enhances antitumor activity of dichloroacetate
by: Kolesnik, D.L., et al.
Published: (2014)

Surface-exposed actin binds plasminogen on the membrane of agonist-activated platelets: a flow cytometry study
by: Tykhomyrov, A.A., et al.
Published: (2017)

The effect of intranasally administered TLR3 agonist larifan on metabolic profile of microglial cells in rat with C6 glioma
by: Y. Hurmach, et al.
Published: (2018)

Women ovarian autoimmunity
by: Yu. Voznesenska, et al.
Published: (2011)

Activation of store – operated Ca2+ entry in cisplatin resistant leukemic cells after treatment with photoexcited fullerene C60 and cisplatin
by: D. V. Franskevych, et al.
Published: (2018)